Ngwaahịa
-
Ejikọtara Ọrịa iku ume
A na-eji ngwa a maka nchọpụta qualitative in vitro nke nje influenza A, nje influenza B, nje syncytial iku ume, adenovirus, rhinovirus mmadụ na mycoplasma pneumoniae nucleic acids na mmadụ nasopharyngeal swabs na oropharyngeal swab samples. Enwere ike iji nsonaazụ ule ahụ mee ihe maka enyemaka maka nyocha nke ọrịa nje na-efe efe nke iku ume, ma na-enye ihe ndabere nchọpụta mkpụrụ ndụ ihe enyemaka maka nyocha na ọgwụgwọ nke ọrịa nje iku ume.
-
Ụdị 14 dị iche iche nke genitourinary tract ọrịa ọrịa
Ezubere ngwa ahụ maka nchọpụta in vitro qualitative chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus ụdị 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus ụdị 2 (HSV2), Mycoplasma (Ureaplasma Hominis), Ureaplasma urealyticum (UU), Herpes simplex virus ụdị 2 (HSV2), Ureaplasma (Ureaplasma). Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), na Treponema pallidum (TP) na mmamịrị, nwoke urethral swab, nwanyị cervical swab, na nwanyị na-arịa ọrịa na-ahụ maka ikpu, na-enye ọgwụgwọ nchoputa na ọgwụgwọ swab ọrịa traktị.
-
SARS-CoV-2/influenza A/influenza B
Nke a kit bụ adabara in vitro qualitative nchọpụta nke SARS-CoV-2, influenza A na influenza B nucleic acid nke nasopharyngeal swab na oropharyngeal swab samples nke ndị mmadụ na-enyo enyo na ọ bụ ọrịa nke SARS-CoV-2, influenza A na influenza B. Ọ nwekwara ike iji na-enyo enyo na pflumoniit ikpe na p. mata SARS-CoV-2, influenza A na influenza B nucleic acid na nasopharyngeal swab na oropharyngeal swab sample nke novel Coronavirus ọrịa n'ọnọdụ ndị ọzọ.
-
OXA-23 Carbapenemase
A na-eji ngwa a maka nchọpụta qualitative nke OXA-23 carbapenemases emepụtara na nje bacteria enwetara mgbe omenala na vitro.
-
Ụdị 18 nke Nje Virus Nucleic Acid Papilloma nke mmadụ nwere nnukwu ihe ize ndụ
Ngwa a dabara adaba maka nchọpụta qualitative in vitro nke ụdị 18 nke nje papilloma mmadụ (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 38, 8 g) nucleic acid. mmamịrị nwoke/nwoke na nwanyị cervical exfoliated cell na HPV 16/18 dee.
-
Klebsiella Pneumoniae, Acinetobacter Baumannii na Pseudomonas Aeruginosa na Drug Resistance Genes (KPC, NDM, OXA48 na IMP) Multiplex
Nke a kit na-eji maka in vitro qualitative nchọpụta nke Klebsiella pneumoniae (KPN), Acinetobacter baumannii (Aba), Pseudomonas aeruginosa (PA) na anọ carbapenem eguzogide mkpụrụ ndụ ihe nketa (nke na-agụnye KPC, NDM, OXA48 na IMP) na mmadụ sputum ọrịa ndabere na-enyo enyo na ọgwụgwọ nke ọgwụ na-enye ndị na-agwọ ọrịa.
-
Mycoplasma pneumoniae (MP)
A na-eji ngwaahịa a maka nchọpụta qualitative in vitro nke Mycoplasma pneumoniae (MP) nucleic acid na sputum mmadụ na nke oropharyngeal swab sample.
-
Clostridium difficile toxin A/B gene (C.diff)
Ezubere ngwa a maka nchọpụta qualitative in vitro nke clostridium difficile toxin A gene na toxin B gene na stool sample si n'aka ndị ọrịa na-enyo enyo na ọrịa clostridium difficile.
-
Clostridium siri ike Glutamate Dehydrogenase (GDH) na Toxin A/B
Ezubere ngwa a maka nchọpụta qualitative in vitro nke Glutamate Dehydrogenase (GDH) na Toxin A/B na stool samples nke ndị a na-enyo enyo na ihe siri ike clostridium.
-
Carbapenemase
A na-eji ngwa a maka nchọpụta qualitative nke NDM, KPC, OXA-48, IMP na VIM carbapenemases emepụtara na nje bacteria enwetara mgbe omenala na vitro gasịrị.
-
Carbapenem Nguzogide Gene (KPC/NDM/OXA 48/OXA 23/VIM/IMP)
A na-eji ngwa a maka nchọpụta qualitative nke carbapenem na-eguzogide mkpụrụ ndụ ihe nketa na sputum sample mmadụ, rectal swab samples ma ọ bụ obodo dị ọcha, gụnyere KPC (Klebsiella pneumonia carbapenemase), NDM (New Delhi metallo-β-lactamase 1), OXA48 (oxacillinase 48), OXA48 (oxacillinase 48), OXA2IM (OXA2) Imipenemase), na IMP (Imipenemase).
-
Influenza A Nje Virus Universal/H1/H3
A na-eji ngwa a maka nchọpụta qualitative nke influenza A nje eluigwe na ala, ụdị H1 na H3 ụdị nucleic acid na mmadụ nasopharyngeal swab samples.
